Structure-based computational design of antibody mimetics: challenges and perspectives

被引:2
|
作者
Chaves, Elton J. F. [1 ]
Coelho, Danilo F. [2 ]
Cruz, Carlos H. B. [3 ]
Moreira, Emerson G. [4 ]
Simoes, Julio C. M. [1 ,2 ]
Nascimento-Filho, Manasses J. [1 ,2 ]
Lins, Roberto D. [1 ,2 ,4 ]
机构
[1] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Recife, Brazil
[2] Univ Fed Pernambuco, Dept Fundamental Chem, Recife, Brazil
[3] UCL, Inst Struct & Mol Biol, London, England
[4] Fiocruz Genom Network, Rio De Janeiro, Brazil
来源
FEBS OPEN BIO | 2025年 / 15卷 / 02期
关键词
de novo design; deep learning; machine learning; protein engineering; protein structure; ARMADILLO REPEAT PROTEINS; HIGH-AFFINITY; BINDING-PROTEINS; OPTIMIZATION; PREDICTION; DYNAMICS; MONOBODIES; SCAFFOLD;
D O I
10.1002/2211-5463.13855
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The design of antibody mimetics holds great promise for revolutionizing therapeutic interventions by offering alternatives to conventional antibody therapies. Structure-based computational approaches have emerged as indispensable tools in the rational design of those molecules, enabling the precise manipulation of their structural and functional properties. This review covers the main classes of designed antigen-binding motifs, as well as alternative strategies to develop tailored ones. We discuss the intricacies of different computational protein-protein interaction design strategies, showcased by selected successful cases in the literature. Subsequently, we explore the latest advancements in the computational techniques including the integration of machine and deep learning methodologies into the design framework, which has led to an augmented design pipeline. Finally, we verse onto the current challenges that stand in the way between high-throughput computer design of antibody mimetics and experimental realization, offering a forward-looking perspective into the field and the promises it holds to biotechnology.
引用
收藏
页码:223 / 235
页数:13
相关论文
共 50 条
  • [41] Perspectives on Inhibiting -Amyloid Aggregation through Structure-Based Drug Design
    Mishra, Pankaj
    Ayyannan, Senthil R.
    Panda, Gautam
    CHEMMEDCHEM, 2015, 10 (09) : 1467 - 1474
  • [42] The Computational Complexity of Structure-Based Causality
    Aleksandrowicz, Gadi
    Chockler, Hana
    Halpern, Joseph Y.
    Ivrii, Alexander
    JOURNAL OF ARTIFICIAL INTELLIGENCE RESEARCH, 2017, 58 : 431 - 451
  • [43] The Computational Complexity of Structure-Based Causality
    Aleksandrowicz, Gadi
    Chockler, Hana
    Halpern, Joseph Y.
    Ivrii, Alexander
    PROCEEDINGS OF THE TWENTY-EIGHTH AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE, 2014, : 974 - 980
  • [44] Affinity Improvement of a Therapeutic Antibody by Structure-Based Computational Design: Generation of Electrostatic Interactions in the Transition State Stabilizes the Antibody-Antigen Complex
    Kiyoshi, Masato
    Caaveiro, Jose M. M.
    Miura, Eri
    Nagatoishi, Satoru
    Nakakido, Makoto
    Soga, Shinji
    Shirai, Hiroki
    Kawabata, Shigeki
    Tsumoto, Kouhei
    PLOS ONE, 2014, 9 (01):
  • [45] Structure-Based Drug Design to Overcome Drug Resistance: Challenges and Opportunities
    Ferreira, Rafaela S.
    Andricopulo, Adriano D.
    CURRENT PHARMACEUTICAL DESIGN, 2014, 20 (05) : 687 - 693
  • [46] Challenges for structure-based drug design against RNA targets.
    Aboul-ela, F
    Morley, SD
    Davis, D
    Klinck, R
    Afshar, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 227 : U1026 - U1026
  • [47] Structure-based design of mimetics for granulocyte-macrophage colony stimulating factor (GM-CSF)
    Monfardini, C
    Canziani, G
    Plugariu, C
    Kieber-Emmons, T
    Godillot, AP
    Kwah, J
    Bajgier, J
    Chaiken, I
    Williams, WV
    CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (24) : 2185 - 2199
  • [48] Molecular Docking of Enzyme Inhibitors A COMPUTATIONAL TOOL FOR STRUCTURE-BASED DRUG DESIGN
    Rudnitskaya, Aleksandra
    Torok, Bela
    Torok, Marianna
    BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION, 2010, 38 (04) : 261 - 265
  • [49] Structure-based drug design
    Stroud, RM
    FASEB JOURNAL, 1997, 11 (09): : A839 - A839
  • [50] Structure-based drug design
    Henry, CM
    CHEMICAL & ENGINEERING NEWS, 2001, 79 (23) : 69 - +